Thus, lab-on-a-chip appears as a viable diagnostic tool since the shrinking of biochemical activities lowers costs, parallelizes operations, and improves diagnostic speed, sensitivity, and accuracy.
Broadcom Inc.’s commentary about the potential of artificial intelligence over the next three years had investors bidding up other stocks across the technology sector — but not shares of ...
Apple plans to phase out the technology that currently powers its Bluetooth and Wi-Fi connections in favor of an in-house chip, further reducing its dependency on third-party providers ...